KRAS and neoplasm: Given the crucial role of KRAS in modulating anti-tumour immune responses, we determined the anti-tumour activity of RMC-4998 and RMC-4550 in treating tumours formed by transplantation of KPARG12C cells, an immunogenic mouse model of NSCLC26.